This comparison is needed because randomization does not always assure a comparable distribution of surrogate markers across a Markov model's HS at baseline.
The degree of varus collapse (8.5 ± 7.7°) and rotation (7.2 ± 6.4°) in cadaveric specimens were comparable to that in surrogate specimens, with the surrogate specimens showing significantly less variability.
To obtain comparable groups of trials using surrogate and final patient relevant outcomes, we used a hierarchical matching process to match each included surrogate outcome trial with a corresponding final patient relevant outcome trial, based on four criteria: the intervention clinical area, clinical population, journal, and publication year (see supplementary file for details of matched studies).
Mass spectrometry of the FFPE tissue surrogates retrieved under elevated pressure showed that both the low and high-abundance proteins were identified with sequence coverage comparable to that of the surrogate mixture prior to formaldehyde treatment.
Furthermore, longitudinal observations in individual patients showed comparable changes in all disease surrogate markers with K2P5.1 expression.
Thus incidence and money spent on cancer services are indicative rather than definitive but are used as a surrogate indicator of comparable incidence of cancer and proportional expenditure on cancers services but nothing on Australia, Canada, Japan and the USA.
For all comparisons, we used comparable combination sizes [57] for surrogates and test features.
Numerous experimental results show that the proposed two-step approach outperforms simpler application strategies of surrogate modelling techniques, getting comparable performances to approaches based on electromagnetic simulation but with orders of magnitude less computational effort.
However, for the hindcast simulation, there were less observed data with greater uncertainty, requiring the use of modern surrogate data or synthesis of comparable data based on assumed differences between past and present conditions.
The frequency of injection site reactions, a surrogate marker of immunoreactivity, was comparable among placebo and active treatment groups.
